← Back to Search

Lipid-lowering agent

Milk Polar Lipids for Abdominal Obesity

Q: Does this experiment permit individuals younger than forty years old to participate?

The age range for those who can join this medical trial is 40 to 70, as set forth in the inclusion criteria.

Q: Who has been deemed qualified to partake in this medical experiment?

In order to qualify for participation in this research, patients should possess <a href="https://www.withpower.com/clinical-trials/obesity">obesity</a> and be between 40-70 years of age. The clinical trial is actively recruiting around 130 participants.

Q: Are there any available openings for this experiment at present?

Based on the details available from clinicaltrials.gov, this study is not currently recruiting patients. It was initially advertised on February 1st 2023 and last edited on January 18th 2023. Fortunately for those interested in participating in a trial, 980 other medical research projects are actively seeking participants at present.

Phase < 1

Recruiting

Research Sponsored by University of Connecticut

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 40 to 70 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial looks at how drinking milk affects heart health and metabolic diseases like diabetes.

Who is the study for?

This trial is for adults aged 40 to 70 with high LDL cholesterol (bad cholesterol) and a large waistline, indicating abdominal obesity. It's not suitable for individuals with gallbladder, thyroid, gut diseases, autoimmune or chronic inflammatory conditions, diabetes, recent antibiotic use, milk allergies/intolerances, or those on certain medications like statins.Check my eligibility

What is being tested?

The study tests if consuming a dairy powder rich in milk polar lipids daily can improve heart health and reduce risk factors associated with heart disease in people with high cholesterol and abdominal obesity.See study design

What are the potential side effects?

Potential side effects are not detailed but may include reactions typical of dairy consumption such as digestive discomfort especially for those who might have undiagnosed lactose intolerance or sensitivity to dairy components.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 40 and 70 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from Baseline Serum LDL Cholesterol at 8 weeks

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: MPL-rich dairy powderExperimental Treatment1 Intervention

Daily consumption of 50 g of dairy powder containing 6.5 g MPL for 8 weeks.

Group II: Control dairy powderPlacebo Group1 Intervention

Daily consumption of 50 g of dairy powder containing <0.1 g MPL for 8 weeks

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Dairy Management Inc.Industry Sponsor

20 Previous Clinical Trials

2,496 Total Patients Enrolled

4 Trials studying Dyslipidemia

789 Patients Enrolled for Dyslipidemia

University of ConnecticutLead Sponsor

184 Previous Clinical Trials

158,163 Total Patients Enrolled

Media Library

Milk Polar Lipid-Rich Dairy Powder (Lipid-lowering agent) Clinical Trial Eligibility Overview. Trial Name: NCT05700916 — Phase < 1

Dyslipidemia Research Study Groups: MPL-rich dairy powder, Control dairy powder

Dyslipidemia Clinical Trial 2023: Milk Polar Lipid-Rich Dairy Powder Highlights & Side Effects. Trial Name: NCT05700916 — Phase < 1

Milk Polar Lipid-Rich Dairy Powder (Lipid-lowering agent) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05700916 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment permit individuals younger than forty years old to participate?

"The age range for those who can join this medical trial is 40 to 70, as set forth in the inclusion criteria."

Answered by AI

Who has been deemed qualified to partake in this medical experiment?

"In order to qualify for participation in this research, patients should possess obesity and be between 40-70 years of age. The clinical trial is actively recruiting around 130 participants."

Answered by AI

Are there any available openings for this experiment at present?

"Based on the details available from clinicaltrials.gov, this study is not currently recruiting patients. It was initially advertised on February 1st 2023 and last edited on January 18th 2023. Fortunately for those interested in participating in a trial, 980 other medical research projects are actively seeking participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

Christopher Blesso 2023. "Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05700916.